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Neurotoxicity is a term used to describe neurophysiological changes caused by exposure to toxic agents. Such exposure can result in
neurocognitive symptoms and/or psychiatric disturbances. Common toxic agents include heavy metals, drugs, organophosphates,
bacterial, and animal neurotoxins. Among heavy metal exposures, lead exposure is one of the most common exposures that can
lead to significant neuropsychological and functional decline in humans. In this review, neurotoxic lead exposure’s pathophysiology,
etiology, and epidemiology are explored. In addition, commonly associated neuropsychological difficulties in intelligence, memory,
executive functioning, attention, processing speed, language, visuospatial skills, motor skills, and affect/mood are explored.
1. Introduction
Neurotoxicity describes neurophysiological changes caused
by exposure to toxic agents, which may result in cognitive
changes, memory disorders, and changes in mood or onset
of psychiatric disturbances (for review refer to Han et al.,
Caban-Holt et al., and Mason et al.) [1–3]. Common toxic
agents include certain heavy metals, drugs, organophos-
phates, bacterial, and animal neurotoxins [4]. Each toxic
agent results in unique presentations, depending on what
neurophysiological changes occur following exposure. Fur-
thermore, toxic exposure can be differentiated by acute
exposure versus chronic exposure, with each type further
affecting symptom presentation and outcomes. Depending
on exposure type, neurotoxic exposure may result in central-
nervous system damage, affective disturbances, and/or neu-
rocognitive disruptions.
Neurotoxicity from heavy metals, including lead, mer-
cury, and arsenic to name a few, is most commonly studied
in two groups: chronic or acute exposure. Acute exposure
often involves rapid onset of nausea, headaches, cognitive
changes, and emotional disruptions. However, heavy metal
exposure is often encountered in industrial workplace envi-
ronments, where chronic, prolonged exposure is more likely.
In such chronic exposure, neurodegeneration and psychiatric
manifestations aremore prevalent. Psychiatricmanifestations
may include increased depression, anxiety, and irritability.
Chronic exposure may also result in prolonged and variable
symptom presentations, including fatigue, decreased pro-
cessing speed, fine and gross motor deficits, and generally
decreased cognitive functioning [4]. The remainder of this
review focuses on neurotoxicity following lead exposure.
Pathophysiology, etiology, and epidemiology are explored,
alongwith commonly associated neuropsychological difficul-
ties.
2. Pb Toxicity
2.1. Pathophysiology. Plumbum (Pb), a chemical element in
the carbon group otherwise known as lead, is a soft and
malleable metal, which is considered a heavy metal. Lead
introduced into the bloodstream is excreted in urine and
bile at a clearance rate of 1 to 3mL/min, with a half-life
of roughly 30 days. The remaining lead binds to red blood
cells, is distributed throughout the soft tissues of the body,
and eventually accumulates in bone. The half-life of bone-
deposited lead ranges from 20 to 30 years. Turnover of bone
tissue releases lead back into the bloodstream, and such
processes as pregnancy,menopause, or lactationmay increase
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blood lead levels by speeding bone tissue turnover. Lead in
the body is measured with both blood and bone levels. Blood
lead levels aremore reflective of acute exposure,whereas bone
lead levels better reflect cumulative exposure over time [5].
The presence of lead in the human body causes damage
to the nervous system through several mechanisms. Direct
effects on the nervous system may be classified as either
morphological or pharmacological [6].Morphological effects
alter the development of the nervous system, particularly
from the prenatal period through childhood. Such effects
include disruption of key molecules during neuronal migra-
tion and differentiation [7]; interference with synapse for-
mation, mediated by a reduction in neuronal sialic acid
production [8]; and premature differentiation of glial cells [9].
Pharmacological effects result from the action of lead
as a pharmacological agent in the CNS. Lead substitutes
for calcium and, to a lesser extent, zinc and inappropriately
triggers processes reliant on calmodulin [10]. Lead also inter-
feres with neurotransmitter release, disrupting the function
of GABAergic, dopaminergic, and cholinergic systems as well
as inhibitingNMDA-ion channels during the neonatal period
[11, 12]. In vitro studies have shown that lead activates protein
kinase C in capillary cells and inhibits Na+/K+-ATPase in the
cell membrane, interfering with energy metabolism [13, 14].
Within the cell, lead appears to interfere with calcium release
from the mitochondria [14], resulting in formation of reac-
tive oxygen species, speeding mitochondrial self-destruction
through formation of the permeability transition pore, and
priming activation of programmed cell death processes [15].
Indirect effects on the nervous system result from inter-
ference with other body systems that support nervous system
function. Lead exposure has been found to increase risk of
numerous conditions that may have adverse effects on ner-
vous system function, including hypertension, impaired renal
function, impaired thyroid function, vitamin D deficiency,
and preterm birth [5]. There has been some debate as to
whether lead exposure affects peripheral nerve conduction
velocity, with some reviews concluding a lack of toxic effect
[16] and others finding significant population-based changes
[17]. The literature appears, at best, to support consistent
subclinical lead effects on nerve conduction velocity [18].
The most severe neurological effect of lead exposure is
lead encephalopathy [19], a response to very high doses of
lead that results in development of irritability, headache,
mental dullness and attention difficulty,memory loss, tremor,
and hallucinations within weeks of exposure. Symptoms
abruptly worsen to paralysis, convulsions, delirium, coma, or
death. Children may develop lead encephalopathy at lower
doses of lead than adults. Postmortem pathological findings
include edema, capillary disruption, proliferation of glia, and
diffuse anoxic injury [17].
2.2. Etiology. Acute high-dose exposure to lead is not the only
source of lead-based neurotoxicity. Acute low-dose expo-
sure also appears to produce measurable, if less dramatic,
effects on nervous system function. Epidemiological studies
have failed to find evidence of a threshold for neurolog-
ical effects; recent large-scale, prospective studies suggest
that blood lead levels below 10 𝜇g/dL significantly worsen
intellectual functioning in children and that the strength of
association is stronger at the low range of exposure [20–22].
Chronic exposure to environmental lead also has mea-
surable effects on the nervous system due to the propensity
for lead to accumulate in the bone over time. For instance,
in an MRI study of 532 former lead workers, high tibia lead
was associatedwith reduced total brain volume, lower volume
of gray matter in the insula and cingulum, and diminished
white matter volume in the parietal lobes [23]. Historically,
the main sources of lead exposure were leaded gasoline,
lead-based paint and plumbing, and solders used in food
packaging. Leaded gasoline was thoroughly phased out of use
by 1986 and is no longer a means of exposure. Similarly, lead
solder in food cans was banned by the FDA in 1995. Lead
plumbing still exists in buildings erected before 1940, and
lead paint, though banned in the United States in 1978, is
still found in some older buildings. These two latter sources
perhaps explain the frequent association of lead exposure
with low socioeconomic status [5, 24, 25].
Occupational lead exposure continues to be a source of
both acute and chronic exposure, resulting in blood levels of
40 to 120𝜇g/dL among participants in case studies and small
cohort studies reviewed by the Agency for Toxic Substance
and Disease Registry [5]. Some evidence suggests that effects
of chronic exposure may persist long after exposure has
ended, which is further discussed in Section 4 of this paper.
Prenatal exposure presents an additional risk for lead
neurotoxicity.Maternal exposure to lead and overallmaternal
body burden of lead are closely associated with lead levels
in the fetus, likely because lead appears to cross the placenta
freely and because pregnancy increases systemic demand for
calcium, resulting in higher bone turnover and consequent
lead release into the bloodstream [26, 27]. Animal studies of
brain lead content have demonstrated that the blood-brain
barrier is particularly ineffective against lead in the prenatal
stage, becoming more effective during weaning and even
more so after weaning [28, 29].
Poor nutrition appears to increase risk of toxic effects
of lead when exposure is held constant. Deficiencies in
calcium, iron, and zinc have been specifically identified as
risk factors. Calcium deficiency appears to increase both
retention of lead and the severity of its toxic effects [30]. Low
intake of dietary iron has similar effects and is perhaps more
important because of relatively high risk of iron deficiency
in childhood [31, 32]. At least one large-scale longitudinal
study has shown that iron deficiency worsens the effects of
lead exposure on neurobehavioral measures and blood cell
production in infants, children, and pregnant women [33].
Zinc deficiency appears to result in a vicious cycle in that
it increases lead absorption, which in turn increases zinc
excretion [34]. The role of nutrition perhaps accounts for
the finding that low socioeconomic status increases risk for
persistence of cognitive deficits after prenatal lead exposure
[35–37].
2.3. Epidemiology. TheNational Health and Nutrition Exam-
ination Survey (NHANES) estimated the prevalence of high
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blood lead levels (>10 𝜇g/dL) among US children to be 8.6%
in the 1988–1991 time period and 1.4% in the 1999–2004
time period, representing an 84% decline. Moreover, the
distribution of blood lead levels among children exhibited
a shift toward lower levels; the majority of US children are
no longer in the range of concern for risk of toxicity [24].
These results suggest that public health reforms targeting lead
exposure were largely successful.
The incidence of lead poisoning is associatedwith numer-
ous factors, including socioeconomic status, rurality, race,
age, and the date one’s residence was built. Inner-city poor
children are at the highest risk, presumably due to the
presence of lead in older building materials and reduced
access to sources of nutrition. NHANES findings from the
1997 survey estimated that 16.4% of children in large cities
and homes built before 1946 had high blood lead levels.
Analyzed according to racial background, African American
children appear to be at the highest risk, followed byMexican
American children, and then European American children
[24]. Younger children appeared to be at additional risk, with
about 9% of children 1–5 years old in the range of concern.
Increased blood lead has also been associated with living in a
rural area, though research on this factor is limited [38].
The Center for Disease Control and Prevention has
identified 25 𝜇g/dL as the lower bound for the range of
concern for adult blood lead levels. Incidence of concerning
levels among adults almost halved from 1994 to 2007, falling
from 14.0/100,000 to 7.8/100,000 [39]. According to the same
study, occupational exposure was the primary source of lead
exposure for adults, particularly in the mining and battery
manufacturing industries. Riskwas found to be higher among
men thanwomenbecause of occupational differences; there is
no such gender difference consistently found among children.
Epidemiological research on international populations is
currently very limited.
3. Neuropsychology of Pb Toxicity
Lead exposure has effects on neuropsychological functioning
that vary across the lifespan. Prospective studies have found
that prenatal exposure, asmeasured by lead levels in umbilical
cord blood, predicted slower development in the sensori-
motor and visuomotor domains, as measured by the Bayley
Scales of Infant Development [40, 41]. Numerous studies
of children have shown that lead exposure reduces overall
cognitive functioning in children, both cross-sectionally
and longitudinally, but most such studies examine omnibus
measures of intellectual functioning rather than domain-
specific effects [35, 42–44]. In adulthood, it is apparent that
chronic exposure to lead is more harmful to cognition than
acute exposures. In a sample of demographically diverse,
primarily middle-aged US adults, bone lead levels predicted
worse cognitive performance in several domains, whereas
blood lead level did not [45]. Researches on domain-specific
cognitive effects are presented below.
3.1. Intelligence. Lowered intellectual scores have been most
commonly noted in children following lead exposure. In
reviewing pediatric cross-sectional studies on intellectual
deficits following lead exposure, 3-point decrements in IQ
have been noted when blood lead concentration increased
from 5 to 20 𝜇g/dL and 5.3-point decrements in IQ when
blood lead concentration increased from 5 to 50𝜇g/dL [46].
Overall evaluation of the studies revealed a fairly consis-
tent association between 1- and 3-point decrements when
blood lead concentrations increased from 10 to 20 𝜇g/dL
[46, 47]. These results suggest a dose-dependent decrease
in intellectual ability following lead exposure, with higher
lead exposure producing larger point decreases. While less
consistently noted than pediatric effects, some decreased
intellectual abilities have also been suggested in adults. The
World Health Organization Program for Chemical Safety
Task Group on Effects of Inorganic Lead [48] reviewed
all extant literature and concluded that blood levels below
25 𝜇g/dL can reduce intellectual functioning in humans, with
every 10 𝜇g/dL increment predicting an IQ decrease of 1–
5 points. Further supporting a dose-dependent effect on
intelligence in adults, increased levels of occupational lead
exposure have been associated with lower overall cognitive
scores and intelligence scores [49]. While initial studies of
the cognitive effects following lead exposure focused on
overall cognitive or intellectual effects, more recent research
suggests the importance of examining domain-specific effects
following lead exposure.
3.2. Memory. Some research has demonstrated lowered
learning and memory scores in occupational lead-exposed
adults [49, 50]. These results suggest that lead exposure is
particularly detrimental in older adults, with individuals of
age 55 and older producing lower learning and memory
scores, among other cognitive declines. Despite this vul-
nerability in older adults, decreased memory performances
have also been noted in adults younger than 55 years of
age who have been exposed to high levels of lead. These
individuals demonstrated decreased performances on verbal
memory and visual memory tasks following lead exposure
[50]. Lower visuospatial memory scores have been con-
sistently documented [49], suggesting that lead exposure
disrupts visuospatial skills and the ability to remember visual
stimuli. Occupational lead exposure is also associated with
lowered visual memory scores, specifically delayed recall
of a complex figure [51]. Lowered verbal memory scores
have also been noted following lead exposure, resulting in
worsened immediate recall, delayed recall, and recognition.
Not only does chronic exposure appear to affect both verbal
and nonverbal memories, but it also appears to produce
progressive decline. In this sample, both verbal and nonverbal
memory tests scores further declined in subsequent years.
This suggests that progressive memory decline may ensue for
years following prolonged exposure [51].
3.3. Executive Functioning and Attention. Several studies
have demonstrated declines in executive functioning follow-
ing occupational lead exposure. Decreased executive func-
tioning abilities on switching and inhibition tasks (Trails
Making Test B and Stroop Task, resp.) have also been
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noted in a group comprised of individuals with a peak lead
exposure of 20𝜇g/g (tibia bone lead measurement) [51].
Lowered executive functioning scores were also found in
earlier research using similar assessments and scores [52].
Unfortunately, much of the research related to executive
functioning is confounded by a visual-motor component.
Thus, the lowered executive functioning scores may also
reflect and/or be exacerbated by processing speed or motor
difficulties, discussed in following sections. Overall, the
evidence is mixed regarding specific executive functioning
deficits following lead exposure.
3.4. Processing Speed. Processing speed deficits following
lead exposure have been noted, with results suggesting a
dose-dependent relationship. Individuals exposed to high
levels of lead have shown slowed decision-making abilities
and reaction times. For instance, significant exposure-related
decrements in decision-making speed and increased gaps in
a detection/reaction time task have been noted [46]. These
results also demonstrated subtle deficits in classification
speed and accuracy in a category search task. These deficits
were only noted in individualswith blood lead concentrations
of 40𝜇g/dL or more. A follow-up study with the same partic-
ipants and testing battery confirmed this dose-dependency
in neurobehavioral deficits [53]. However, both studies noted
the main finding to be slowed sensory motor reaction time,
which may have artificially lowered overall processing speed.
3.5. Language. In the language domain, the literature has
consistently identified effects of lead exposure on comprehen-
sion and reading ability. In children, lead exposure has been
associated with impaired verbal concept formation [54], poor
grammatical reasoning [55], and poor command following
on both standardized and in situ tasks [56]. Grammatical
reasoning difficulty was also associated with lead exposure in
a study of adult lead workers [53, 57]. The NHANES survey
of 4,853 US children found significant effects of blood lead
level on reading ability [58], as did a study of 501 children
in Scotland [59]. The New England Children’s Amalgam
Trial (NECAL) found that moderate blood levels of lead (5–
10 𝜇g/dL) predicted lower vocabulary performance among
534 children of ages 6–10 fromurbanMassachusetts and rural
Maine [20]. A study of older men similarly demonstrated
blood lead effects on the ability to definewords and also found
an effect on visual naming of contour drawings [60]. Non-
word repetition deficits were associated with bone lead level
in a sample of adolescent boys [56], but the task has not been
repeated with other age groups.
3.6. Visuospatial Skills. The visuospatial domain of cognition
appears to be particularly vulnerable to effects of lead toxicity.
In adults of age 55 and older, higher bone lead level was asso-
ciated with worse visuospatial function, as measured with
visual reproductions, embedded figures, and block design
tasks, and predicted further more decline in that domain
relative to nonexposed controls after a 22-year delay [49]. A
meta-analytic review of 22 studies of lead workers concluded
that high blood lead levels are associated with significant
effects on a block design task [61]. Another meta-analysis
of 22 studies failed to replicate these results but did find
significant effects on a task of speeded visual discrimination.
In the Normative Aging Study, 141 older male participants
were grouped according to blood lead level and by bone lead
level [60]. Those with higher blood lead level required more
time to produce accurate visual comparisons. Those with
high blood and bone lead levels produced poorer copies of
geometric figures and recalled visual patternsmore poorly. In
one study of adults, perceptual speed appeared to be affected
by chronic lead exposure in a dose-dependent manner [62].
Blood lead level has been associated with poorer visuomotor
integration in studies of Yugoslavian and primarily African
American children [63–67] and, in one sample, blood lead
levels measured in the sixth year of life predicted poorer
visual construction at age 17 [67]. Neurologic examination
uncovered impaired size discrimination and visual pursuit in
a sample of Andean children as well [68].
3.7. Motor Skills. Lead exposure has long been known to dis-
turb motor function. Particularly, visuomotor coordination
impairment has been reported in studies of adult leadworkers
[54, 69–71] and lead-exposed children [55]. Manual dexterity
has been demonstrated to suffer in a dose-dependentmanner
in lead workers from Republic of Korea and Venezuela
[52, 62]. Moreover, baseline blood and bone lead levels in
chronically exposed workers predicted the extent of further
decline in manual dexterity over the course of 5 years [52].
In addition, the effects on visuomotor integration, studies
of Yugoslavian and urban African American children found
blood lead level to predict significantly poorer fine motor
skills [63–66]. Gross motor speed, as measured by a finger
tapping task, appears to be affected in lead-exposed children
as well [55, 68].
3.8. Affect. Lead-related changes in affect are less researched
than other functional domains. A study of 526 older adults in
the Normative Aging Study found that anxiety, depression,
and phobia were positively correlated with bone lead level
[72]. Lead workers with high blood lead levels have been
reported to experience greater interpersonal conflict than
their less-exposed counterparts [73], and a review of 14
studies of low-level lead exposure concluded that lead-related
interpersonal problems may be mediated by irritability and
fatigue [74].
There is also growing evidence of early lead exposure link-
ing to increased frequency of antisocial behavior including
violent behavior [75]. A number of studies are revealing that
antisocial tendencies like violent and aggressive behaviors
correlate with environmental stressors like lead or polychlori-
nated biphenyls, beyond that of socioeconomic factors [76].
A 2010 study of 173 Brazilian adolescents with high level of
surface dental enamel related lead exposure revealed a link
with antisocial behavior, calling out for public policies to
prevent lead poisoning [77].
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4. Outcome
Outcome following toxic lead exposure is dependent on
several factors, including duration, amount of exposure, and
age. Acute, high-level exposure and chronic low-level expo-
sure each have differing outcomes. While individuals with
asymptomatic lead exposure demonstrate the best outcomes,
those who become symptomatic after exposure to acute
high levels of lead often also demonstrate good outcomes.
High-level exposure presents initially as lethargy and later
progresses to coma and seizures. Death is rare if exposure
is expediently and appropriately treated, but may occur if
increased cranial pressure secondary to encephalopathy is
prolonged [78]. As discussed later, nephropathy due to acute
lead exposure may be reversible in some cases. Individuals
exposed to chronic low levels of lead are likely to exhibit
worse prognosis, with the potential for progressive renal
decline, lower sperm counts or impotence in males, increases
in miscarriage and smaller babies in females, and increased
depression, aggression, and other affective disorders [78].
Despite these potentially serious consequences, other than
some motor difficulties and increased affective disorders,
most lead exposure is not likely to produce long-term
cognitive changes in adults [78].
However, there is some evidence that occupational lead
exposuremay continue to cause progressive cognitive deficits
years after exposure [49, 79]. In a sample of 535 former
lead workers, bone lead levels measured 16 years after last
exposure were associated with poorer cognitive performance
[80] and predicted progressive decline [51, 79]. Some research
also suggests increased vulnerability for cognitive difficulties
in older populations, with high levels of bone lead predicting
lower cognitive performances in individuals over the age of
55 [49]. Finally, pediatric exposure has been shown to have
far more drastic consequences than adult exposure. Pediatric
lead exposure often results in more severe neurological dam-
age, as demonstrated by associations between exposure and
long-term difficulties with learning and overall intelligence
[46, 78].
5. Neurorehabilitation
The primary focus of treatment for lead exposure is to
reduce the level of circulating lead in the bloodstream. To
that end, the first-line intervention for lead poisoning is
to cease lead exposure and administer chelation therapy.
Chelation involves introduction of one or more agents that
bind with lead and facilitate its excretion. Recommended
chelation agents include oral meso-2,3-dimercaptosuccinic
acid (DMSA) and intravenous or intramuscular ethylenedi-
aminetetraacetic acid (EDTA). Encephalopathic individuals
with severe, acute lead toxicity are usually treated with
intramuscular dimercaprol, either alone or in combination
with EDTA. Both cessation of lead exposure and chelation
effectively lower blood lead levels, reducing pharmacological
effects of lead, but they show no therapeutic benefit against
morphological changes [6].
Two large, double-blind, randomized, placebo-controlled
trials of chelation therapy for children foundno improvement
in neuropsychological function [81, 82]. However, effects
of acute exposure on neurocognitive performance do show
some evidence of reversibility. Removal of exposure and sub-
sequent reduction of blood lead levels have been associated
with improvements in verbal memory performance [83],
visual memory performance, gross motor speed, and visual
discrimination speed [84]. There is no compelling evidence
for effective neurorehabilitation of deficits due to chronic lead
exposure.
6. Discussion
Neurotoxicity involves cognitive, affective, and physiological
changes caused by toxic exposure. Some of themost common
toxic agents include heavy metals, and acute and chronic
exposure to heavy metal Pb can induce significant neu-
rophysiological and neuropsychological deficits, depending
on the level of exposure. Consistent neuropsychological
research over the years has revealed that Pb exposure can
result in declines in intelligence, memory, processing speed,
comprehension and reading, visuospatial skills, motor skills,
and, to a probable lesser extent, executive skills. Among the
cognitive deficits induced by Pb toxicity, visuospatial deficits
appear to be notably prominent. Anxiety, depression, and
phobia can also occur, while outcome, intervention, and
rehabilitation results are largely dependent on the level of
toxic exposure. There is also a growing evidence of antisocial
behavior linked to early lead exposure.
Early detection, accurate assessment, and treatment are
important, especially since earlier intervention may aid in
reversal of certain posttoxicity sequelae. Deficits due to
chronic exposure pose less favorable outcomes, making
early detection and intervention that much more impor-
tant. Utilization of this review’s neuropsychological and
neurophysiological profiles after Pb toxic exposure may aid
in accurate clinical detection, intervention, assessment for
tracking recovery, and policy development.
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